Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Cas No. | 1258595-14-0 |
|---|---|
| Purity | ≥99% |
| Formula | C29H32F2N3O7P |
| Formula Wt. | 603.56 |
| IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
| Synonym | LHC165 |
| Appearance | Pale yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Labdane diterpene found in Andrographis; RLR (R...
Pneumonia antigen
Pt-based DNA cross-linker.
PAI-1 inhibitor.
Fermentation impurity
Proteasome inhibitor.
KRAS inhibitor
Anthraquinone found in Rheum.
Hydrophobic β-lactam; penicillin binding prote...
Sesquiterpene alcohol found in various essentia...
Anthraquinone found in various plant sources; C...
Estradiol metabolite.
Coumarin glucoside found in Aesculus, Daphne, a...
MAO-A/B inhibitor.
JAK2 inhibitor.
Quinoline; PDE 3B inhibitor.
Fluoroquinolone; topoisomerase IV and bacterial...
T-type Ca2+ and voltage-gated Na+ channel block...
Monoterpene; nAChR antagonist.
Endogenous peptide hormone, involved in secreti...